ANGELA CASMIER: Open Payments
NPI 1568670818 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 41 payments from 8 companies in 2025. Trend: 2023 $377 · 2024 $408 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $147 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| ABBVIE INC. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: CAPLYTA, AUSTEDO XR, INGREZZA, REXULTI, ABILIFY ASIMTUFII, FANAPT, VRAYLAR, UZEDY.
Industry payments across MT — which companies pay providers there.
